SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]

SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] was reported 13295 times

Drugs of the SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CLINICAL TRIAL PARTICIPANT 21 0.3684
1 MASKED FEVER 5 0.3571
2 PULMONARY TRICHOSPORONOSIS 8 0.3478
3 COVID-19 TREATMENT 21 0.3088
4 MITRAL PERFORATION 4 0.2500
5 LACTOBACILLUS BACTERAEMIA 4 0.1905
6 SARS-COV-2 RNA INCREASED 11 0.1618
7 PARAVENOUS DRUG ADMINISTRATION 6 0.1395
8 COINFECTION 9 0.1304
9 RHINOCEREBRAL MUCORMYCOSIS 39 0.1124
10 CRYPTOCOCCAL MENINGOENCEPHALITIS 13 0.0992
11 PNEUMONIA SERRATIA 4 0.0870
12 CUTANEOUS MUCORMYCOSIS 15 0.0815
13 BRONCHOPLEURAL FISTULA 29 0.0771
14 ISOSPORIASIS 6 0.0769
15 HEPATIC AMOEBIASIS 5 0.0746
16 OCULOAURICULOVERTEBRAL DYSPLASIA 5 0.0694
17 PULMONARY MUCORMYCOSIS 36 0.0682
18 LUNG ASSIST DEVICE THERAPY 4 0.0645
19 BORDETELLA INFECTION 5 0.0556
20 RENAL REPLACEMENT THERAPY 7 0.0547
21 MESENTERIC HAEMORRHAGE 4 0.0465
22 AMOEBIC COLITIS 4 0.0440
23 NATURAL KILLER CELL COUNT DECREASED 4 0.0435
24 HUMORAL IMMUNE DEFECT 16 0.0431
25 COVID-19 PNEUMONIA 505 0.0427
26 MYCOTIC ENDOPHTHALMITIS 8 0.0423
27 GASTROINTESTINAL MUCORMYCOSIS 7 0.0419
28 HERPES SIMPLEX REACTIVATION 15 0.0394
29 DRUG RESISTANCE MUTATION 7 0.0393
30 PNEUMOMEDIASTINUM 71 0.0392
31 CEREBRAL NOCARDIOSIS 9 0.0386
32 DISSEMINATED ASPERGILLOSIS 18 0.0381
33 PULMONARY NECROSIS 12 0.0352
34 CRYPTOCOCCAL FUNGAEMIA 5 0.0350
35 INTESTINAL BARRIER DYSFUNCTION 4 0.0345
36 ACQUIRED MACROGLOSSIA 3 0.0337
37 SUBCUTANEOUS EMPHYSEMA 33 0.0336
38 BAROTRAUMA 3 0.0326
39 MUCORMYCOSIS 84 0.0323
40 HAEMORRHAGIC CHOLECYSTITIS 4 0.0320
41 DISSEMINATED STRONGYLOIDIASIS 7 0.0320
42 PNEUMONIA CRYPTOCOCCAL 30 0.0317
43 DIVERTICULITIS INTESTINAL PERFORATED 11 0.0308
44 DISSEMINATED MUCORMYCOSIS 12 0.0305
45 ASPERGILLUS TEST POSITIVE 9 0.0292
46 DISSEMINATED CRYPTOCOCCOSIS 22 0.0291
47 CYSTIC LUNG DISEASE 4 0.0282
48 MYOPATHY TOXIC 17 0.0275
49 ACINETOBACTER BACTERAEMIA 5 0.0266
50 BRONCHOPULMONARY ASPERGILLOSIS 206 0.0265
51 PULMONARY AIR LEAKAGE 4 0.0265
52 SUPERINFECTION BACTERIAL 21 0.0265
53 HAEMOFILTRATION 5 0.0263
54 SPONTANEOUS BACTERIAL PERITONITIS 6 0.0246
55 BURKHOLDERIA TEST POSITIVE 3 0.0242
56 INFECTION REACTIVATION 27 0.0236
57 ACUTE RIGHT VENTRICULAR FAILURE 4 0.0235
58 ISCHAEMIC HEPATITIS 32 0.0234
59 CYTOKINE STORM 16 0.0234
60 CHEST WALL HAEMATOMA 6 0.0233
61 B-CELL APLASIA 6 0.0233
62 POST-ACUTE COVID-19 SYNDROME 28 0.0226
63 INFUSION SITE EXTRAVASATION 136 0.0218
64 MONOCYTE PERCENTAGE DECREASED 4 0.0217
65 RECALLED PRODUCT 37 0.0214
66 AMOEBIASIS 5 0.0213
67 JEJUNAL PERFORATION 5 0.0207
68 PULMONARY CAVITATION 18 0.0207
69 PNEUMOTHORAX SPONTANEOUS 14 0.0206
70 VACCINATION FAILURE 34 0.0204
71 CRYPTOCOCCOSIS 33 0.0202
72 EOSINOPHIL PERCENTAGE DECREASED 4 0.0201
73 DIFFUSE ALVEOLAR DAMAGE 23 0.0200
74 CARDIAC ASTHMA 3 0.0200
75 PNEUMONIA STAPHYLOCOCCAL 39 0.0197
76 LIVER FUNCTION TEST INCREASED 422 0.0196
77 VACCINE INTERACTION 6 0.0194
78 GEOTRICHUM INFECTION 4 0.0190
79 BACTERIAL ENDOPHTHALMITIS 5 0.0188
80 STENOTROPHOMONAS INFECTION 25 0.0184
81 PULMONARY NOCARDIOSIS 15 0.0182
82 FUNGAEMIA 28 0.0178
83 HAEMOPERITONEUM 14 0.0175
84 PULSELESS ELECTRICAL ACTIVITY 73 0.0175
85 APGAR SCORE LOW 22 0.0171
86 PNEUMONIA NECROTISING 11 0.0170
87 PNEUMONIA PSEUDOMONAL 26 0.0169
88 CORYNEBACTERIUM INFECTION 9 0.0168
89 CANDIDA TEST POSITIVE 7 0.0167
90 PURPURA FULMINANS 4 0.0157
91 RETROPERITONEAL HAEMATOMA 34 0.0154
92 ALANINE AMINOTRANSFERASE INCREASED 935 0.0152
93 PRIMARY BILIARY CHOLANGITIS 7 0.0149
94 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 12 0.0146
95 CYTOMEGALOVIRUS ENTEROCOLITIS 11 0.0143
96 MECHANICAL VENTILATION 27 0.0142
97 CEREBRAL FUNGAL INFECTION 4 0.0141
98 BURKHOLDERIA CEPACIA COMPLEX INFECTION 4 0.0140
99 PERIOSTITIS 6 0.0139
100 VASOGENIC CEREBRAL OEDEMA 10 0.0139
101 PNEUMONIA BACTERIAL 124 0.0135
102 SINUS BRADYCARDIA 129 0.0133
103 FUNGAL ENDOCARDITIS 4 0.0133
104 HUMAN HERPESVIRUS 8 INFECTION 8 0.0131
105 ASPERGILLUS INFECTION 86 0.0131
106 CEREBRAL ASPERGILLOSIS 8 0.0130
107 FIBRIN D DIMER INCREASED 45 0.0126
108 TRANSIENT TACHYPNOEA OF THE NEWBORN 5 0.0126
109 SARS-COV-2 ANTIBODY TEST NEGATIVE 6 0.0125
110 PALLIATIVE CARE 19 0.0124
111 PNEUMONIA CYTOMEGALOVIRAL 24 0.0123
112 SPUTUM CULTURE POSITIVE 10 0.0123
113 SPLENIC ABSCESS 5 0.0123
114 BRADYCARDIA 652 0.0123
115 ALLERGIC RESPIRATORY SYMPTOM 4 0.0120
116 EXTRAVASATION 49 0.0119
117 ASPARTATE AMINOTRANSFERASE INCREASED 629 0.0118
118 PNEUMOCOCCAL INFECTION 7 0.0118
119 RETROPERITONEAL HAEMORRHAGE 29 0.0117
120 PROPOFOL INFUSION SYNDROME 8 0.0113
121 MUSCLE ABSCESS 7 0.0112
122 BONE INFARCTION 5 0.0110
123 INTERLEUKIN LEVEL INCREASED 6 0.0109
124 HAEMATOMA MUSCLE 13 0.0108
125 INFUSION SITE OEDEMA 9 0.0108
126 ENCEPHALOMALACIA 6 0.0107
127 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 4 0.0105
128 ACUTE RESPIRATORY DISTRESS SYNDROME 186 0.0105
129 INFECTIOUS PLEURAL EFFUSION 16 0.0105
130 HYPERBILIRUBINAEMIA NEONATAL 6 0.0103
131 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 5 0.0103
132 CARDIAC VALVE VEGETATION 5 0.0103
133 HYPERTRANSAMINASAEMIA 71 0.0102
134 HAEMOPHILUS INFECTION 10 0.0102
135 BLOOD FIBRINOGEN INCREASED 8 0.0101
136 RENAL TRANSPLANT FAILURE 10 0.0101
137 NECROTISING OESOPHAGITIS 5 0.0100
138 TRICHOSPORON INFECTION 4 0.0099
139 OPPORTUNISTIC INFECTION 18 0.0097
140 GLOMERULAR FILTRATION RATE INCREASED 8 0.0097
141 AMNIOTIC CAVITY INFECTION 7 0.0097
142 GLOMERULAR FILTRATION RATE DECREASED 117 0.0095
143 CREATININE RENAL CLEARANCE INCREASED 7 0.0094
144 CHORIORETINITIS 6 0.0093
145 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 7 0.0093
146 KLEBSIELLA INFECTION 47 0.0093
147 BLOOD GASES ABNORMAL 5 0.0093
148 CONTINUOUS HAEMODIAFILTRATION 9 0.0092
149 SYSTEMIC CANDIDA 23 0.0092
150 ADMINISTRATION SITE EXTRAVASATION 9 0.0090
151 RENAL INFARCT 13 0.0090
152 REFUSAL OF TREATMENT BY RELATIVE 4 0.0088
153 PELVIC ABSCESS 10 0.0087
154 ENTEROCOCCAL INFECTION 42 0.0087
155 INFANTILE APNOEA 7 0.0086
156 ACUTE RESPIRATORY FAILURE 165 0.0086
157 PROCALCITONIN INCREASED 10 0.0085
158 NEONATAL RESPIRATORY DISTRESS 8 0.0085
159 ORGANISING PNEUMONIA 42 0.0085
160 PNEUMOTHORAX 134 0.0084
161 BRADYCARDIA FOETAL 7 0.0084
162 ENTEROBACTER INFECTION 14 0.0083
163 CREATININE RENAL CLEARANCE DECREASED 33 0.0082
164 MULTIPLE ORGAN DYSFUNCTION SYNDROME 233 0.0082
165 PNEUMONIA KLEBSIELLA 15 0.0082
166 TRANSAMINASES INCREASED 178 0.0080
167 NECROTISING RETINITIS 5 0.0078
168 BLOOD MAGNESIUM INCREASED 7 0.0078
169 SINUS ARREST 12 0.0076
170 LUNG ABSCESS 16 0.0076
171 PREMATURE DELIVERY 121 0.0076
172 RESPIRATORY FAILURE 552 0.0076
173 HYPOXIA 261 0.0074
174 CENTRAL SEROUS CHORIORETINOPATHY 5 0.0073
175 PNEUMONIA STREPTOCOCCAL 8 0.0073
176 MARASMUS 11 0.0072
177 PNEUMONIA VIRAL 23 0.0072
178 FOETAL HEART RATE DECELERATION ABNORMALITY 5 0.0071
179 SHOCK HAEMORRHAGIC 57 0.0070
180 LEGIONELLA INFECTION 4 0.0070
181 OPHTHALMIC HERPES SIMPLEX 4 0.0069
182 LUNG OPACITY 18 0.0068
183 SARS-COV-2 TEST POSITIVE 90 0.0068
184 ENDOTRACHEAL INTUBATION 19 0.0068
185 PNEUMOCYSTIS JIROVECII INFECTION 8 0.0067
186 ABDOMINAL WALL HAEMATOMA 13 0.0067
187 VIRAL MUTATION IDENTIFIED 24 0.0065
188 TRACHEOBRONCHITIS 5 0.0065
189 RECALLED PRODUCT ADMINISTERED 62 0.0065
190 CRITICAL ILLNESS 5 0.0064
191 MICROANGIOPATHY 6 0.0064
192 SEPTIC SHOCK 277 0.0064
193 HAEMODIALYSIS 53 0.0063
194 OXYGEN CONSUMPTION INCREASED 15 0.0063
195 BRONCHOPULMONARY DYSPLASIA 5 0.0062
196 STAPHYLOCOCCAL BACTERAEMIA 27 0.0062
197 ENDOCARDITIS 31 0.0060
198 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 327 0.0060
199 PNEUMOPERITONEUM 11 0.0059
200 PRODUCT PREPARATION ISSUE 39 0.0059
201 HEPATITIS B DNA INCREASED 4 0.0059
202 NEONATAL RESPIRATORY DISTRESS SYNDROME 21 0.0059
203 ATRIOVENTRICULAR BLOCK SECOND DEGREE 18 0.0059
204 ABSCESS NECK 4 0.0059
205 PULSE ABSENT 28 0.0059
206 COCCIDIOIDOMYCOSIS 7 0.0059
207 TRANSCRIPTION MEDICATION ERROR 9 0.0057
208 SPLENIC INFARCTION 10 0.0057
209 MENINGITIS CRYPTOCOCCAL 10 0.0057
210 HISTOPLASMOSIS DISSEMINATED 9 0.0057
211 ENTEROCOCCAL BACTERAEMIA 6 0.0057
212 HYPERLEUKOCYTOSIS 5 0.0056
213 INFLAMMATORY MARKER INCREASED 28 0.0056
214 STRONGYLOIDIASIS 9 0.0056
215 DISSEMINATED INTRAVASCULAR COAGULATION 78 0.0055
216 LISTERIOSIS 6 0.0054
217 EPSTEIN-BARR VIRAEMIA 6 0.0054
218 PNEUMONIA PNEUMOCOCCAL 8 0.0054
219 HYPERTHERMIA MALIGNANT 8 0.0054
220 BRAIN STEM SYNDROME 4 0.0053
221 STEROID DIABETES 8 0.0053
222 KLEBSIELLA BACTERAEMIA 5 0.0053
223 COVID-19 919 0.0052
224 CEREBRAL VENTRICLE DILATATION 6 0.0052
225 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 39 0.0052
226 FOETAL DISTRESS SYNDROME 11 0.0052
227 METHAEMOGLOBINAEMIA 12 0.0052
228 TORSADE DE POINTES 40 0.0051
229 ENDOCARDITIS BACTERIAL 4 0.0051
230 PRINZMETAL ANGINA 5 0.0050
231 EMPYEMA 10 0.0050
232 DISEASE COMPLICATION 23 0.0050
233 HYPOVOLAEMIC SHOCK 24 0.0050
234 HAEMODYNAMIC INSTABILITY 38 0.0050
235 HYPERCAPNIA 15 0.0050
236 CHRONIC RESPIRATORY FAILURE 6 0.0050
237 BLOOD CREATINE INCREASED 22 0.0050
238 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 13 0.0050
239 BLOOD CREATININE INCREASED 323 0.0049
240 CHORIORETINOPATHY 7 0.0049
241 SINUS NODE DYSFUNCTION 9 0.0049
242 PNEUMATOSIS INTESTINALIS 14 0.0049
243 LOW BIRTH WEIGHT BABY 39 0.0049
244 RENAL ABSCESS 4 0.0049
245 VASOPLEGIA SYNDROME 8 0.0049
246 OXYGEN THERAPY 8 0.0049
247 CORONAVIRUS TEST POSITIVE 5 0.0049
248 BLOOD LOSS ANAEMIA 11 0.0049
249 NEONATAL HYPOXIA 4 0.0048
250 NORMOCYTIC ANAEMIA 7 0.0048
251 WHITE MATTER LESION 6 0.0047
252 CEREBRAL VENOUS SINUS THROMBOSIS 4 0.0047
253 ORGAN FAILURE 19 0.0047
254 PSEUDOMONAL BACTERAEMIA 4 0.0047
255 IMMUNOSUPPRESSION 41 0.0046
256 URINARY TRACT OBSTRUCTION 11 0.0046
257 DRUG CLEARANCE DECREASED 6 0.0046
258 PNEUMONIA FUNGAL 18 0.0046
259 B-LYMPHOCYTE COUNT DECREASED 6 0.0044
260 ACIDOSIS 33 0.0043
261 ANGLE CLOSURE GLAUCOMA 11 0.0043
262 CYTOMEGALOVIRUS VIRAEMIA 19 0.0043
263 SHOCK 97 0.0042
264 HYPERNATRAEMIA 21 0.0042
265 CATATONIA 22 0.0042
266 ALANINE AMINOTRANSFERASE DECREASED 3 0.0041
267 ACUTE KIDNEY INJURY 630 0.0041
268 RESPIRATORY ACIDOSIS 16 0.0041
269 MULTI-ORGAN DISORDER 8 0.0041
270 LARGE INTESTINAL ULCER 11 0.0040
271 BACTERAEMIA 48 0.0040
272 HEPATITIS FULMINANT 12 0.0040
273 PUPIL FIXED 7 0.0040
274 PRODUCT PREPARATION ERROR 83 0.0040
275 GASTROINTESTINAL WALL THICKENING 6 0.0040
276 PSEUDOMONAL SEPSIS 7 0.0040
277 THERAPY CESSATION 205 0.0040
278 PNEUMOCYSTIS JIROVECII PNEUMONIA 40 0.0040
279 RENAL TUBULAR NECROSIS 39 0.0040
280 PSEUDOMONAS INFECTION 34 0.0040
281 TRANSPLANT DYSFUNCTION 7 0.0039
282 PANCREATITIS NECROTISING 9 0.0039
283 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 6 0.0039
284 COUNTERFEIT PRODUCT ADMINISTERED 5 0.0038
285 ENTHESOPATHY 6 0.0038
286 LATENT TUBERCULOSIS 8 0.0038
287 PULMONARY INFARCTION 9 0.0038
288 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 5 0.0038
289 STAPHYLOCOCCUS TEST POSITIVE 8 0.0038
290 INTRA-ABDOMINAL HAEMORRHAGE 9 0.0038
291 TACHYPNOEA 51 0.0037
292 CEREBRAL ARTERY OCCLUSION 4 0.0037
293 GALLBLADDER ENLARGEMENT 4 0.0037
294 TOXOPLASMOSIS 4 0.0037
295 BLOOD SODIUM INCREASED 10 0.0037
296 OXYGEN SATURATION DECREASED 208 0.0037
297 RESPIRATORY ALKALOSIS 6 0.0037
298 GASTRIC PERFORATION 10 0.0037
299 FOETAL DEATH 19 0.0037
300 ACINETOBACTER INFECTION 4 0.0037
301 PREMATURE BABY 109 0.0036
302 BRAIN DEATH 11 0.0036
303 HYPOGAMMAGLOBULINAEMIA 23 0.0035
304 CARBON DIOXIDE DECREASED 4 0.0035
305 CARDIAC ARREST 286 0.0035
306 CYTOMEGALOVIRUS TEST POSITIVE 6 0.0034
307 RENAL IMPAIRMENT 282 0.0034
308 PRODUCT CONTAMINATION MICROBIAL 4 0.0034
309 LIVEDO RETICULARIS 7 0.0033
310 CANDIDA SEPSIS 3 0.0033
311 PROTHROMBIN TIME PROLONGED 20 0.0033
312 INFUSION SITE SWELLING 21 0.0033
313 SUPERINFECTION 5 0.0033
314 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 11 0.0033
315 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 11 0.0033
316 ALANINE AMINOTRANSFERASE ABNORMAL 7 0.0033
317 HEPATOCELLULAR INJURY 47 0.0033
318 INTERNATIONAL NORMALISED RATIO INCREASED 94 0.0033
319 CANDIDA INFECTION 55 0.0033
320 EMBOLISM 27 0.0032
321 HEPARIN-INDUCED THROMBOCYTOPENIA 16 0.0032
322 SUPRAVENTRICULAR TACHYCARDIA 31 0.0032
323 OXYGEN SATURATION ABNORMAL 9 0.0032
324 GASTRIC ULCER PERFORATION 4 0.0032
325 PULMONARY TUBERCULOSIS 13 0.0030
326 INTERCEPTED PRODUCT DISPENSING ERROR 5 0.0030
327 LIVER INJURY 74 0.0030
328 BLOOD CULTURE POSITIVE 9 0.0030
329 METABOLIC ENCEPHALOPATHY 9 0.0030
330 LEUKOCYTOSIS 54 0.0030
331 PNEUMONIA ASPIRATION 74 0.0030
332 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 23 0.0030
333 ELECTROCARDIOGRAM QT PROLONGED 106 0.0029
334 HERPES SIMPLEX 19 0.0029
335 HEPATIC FUNCTION ABNORMAL 109 0.0029
336 ESCHERICHIA INFECTION 24 0.0029
337 DIVERTICULAR PERFORATION 6 0.0029
338 OLIGURIA 18 0.0029
339 DIALYSIS 41 0.0029
340 DEATH NEONATAL 4 0.0029
341 ACUTE HEPATIC FAILURE 39 0.0029
342 PERIPHERAL ARTERY OCCLUSION 4 0.0028
343 GLOMERULAR FILTRATION RATE ABNORMAL 4 0.0028
344 BLOOD ALKALINE PHOSPHATASE INCREASED 70 0.0028
345 MENINGITIS BACTERIAL 4 0.0028
346 HYPERPHOSPHATAEMIA 6 0.0028
347 BACTERIAL SEPSIS 9 0.0028
348 HYPERSEXUALITY 5 0.0027
349 LARGE INTESTINE PERFORATION 19 0.0027
350 MYASTHENIA GRAVIS CRISIS 4 0.0027
351 RESPIRATORY DISTRESS 74 0.0027
352 INFUSION SITE REACTION 8 0.0027
353 ENDOPHTHALMITIS 16 0.0027
354 STAPHYLOCOCCAL SEPSIS 13 0.0026
355 PATHOGEN RESISTANCE 24 0.0026
356 BLOOD BILIRUBIN INCREASED 71 0.0026
357 PREMATURE SEPARATION OF PLACENTA 4 0.0026
358 AORTIC VALVE INCOMPETENCE 11 0.0026
359 COAGULOPATHY 43 0.0026
360 BILIRUBIN CONJUGATED INCREASED 6 0.0026
361 OFF LABEL USE 2245 0.0026
362 MEGACOLON 4 0.0025
363 PATENT DUCTUS ARTERIOSUS 10 0.0025
364 DRUG-INDUCED LIVER INJURY 79 0.0025
365 HEPATOTOXICITY 56 0.0025
366 PULMONARY FUNCTION TEST DECREASED 11 0.0025
367 HEPATIC CYTOLYSIS 32 0.0025
368 TROPONIN INCREASED 19 0.0025
369 ANTIPHOSPHOLIPID SYNDROME 4 0.0025
370 GUILLAIN-BARRE SYNDROME 12 0.0025
371 CEREBRAL ARTERY EMBOLISM 3 0.0025
372 HAEMATOLOGICAL INFECTION 6 0.0025
373 BLOOD UREA INCREASED 41 0.0024
374 MATERNAL EXPOSURE DURING PREGNANCY 217 0.0024
375 VENTRICULAR TACHYCARDIA 40 0.0024
376 HEART RATE DECREASED 84 0.0024
377 ATRIOVENTRICULAR BLOCK COMPLETE 16 0.0024
378 LUNG INFILTRATION 21 0.0024
379 GASTRITIS EROSIVE 11 0.0024
380 INFUSION SITE BRUISING 5 0.0023
381 PULMONARY HAEMORRHAGE 18 0.0023
382 CYTOMEGALOVIRUS INFECTION 38 0.0023
383 RESPIRATORY DISORDER 68 0.0023
384 NOSOCOMIAL INFECTION 5 0.0023
385 NECROTISING FASCIITIS 8 0.0023
386 VENTRICULAR FIBRILLATION 25 0.0022
387 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 5 0.0022
388 IRON DEFICIENCY 10 0.0022
389 KOUNIS SYNDROME 5 0.0022
390 METABOLIC ACIDOSIS 70 0.0022
391 THROMBOCYTOSIS 8 0.0022
392 EUGLYCAEMIC DIABETIC KETOACIDOSIS 9 0.0022
393 INTESTINAL ISCHAEMIA 12 0.0022
394 HEPATIC ENZYME INCREASED 148 0.0022
395 STAPHYLOCOCCAL INFECTION 71 0.0022
396 CARDIO-RESPIRATORY ARREST 90 0.0022
397 BLOOD LACTATE DEHYDROGENASE INCREASED 34 0.0021
398 REFUSAL OF TREATMENT BY PATIENT 14 0.0021
399 INFUSION SITE ERYTHEMA 18 0.0021
400 JAUNDICE NEONATAL 4 0.0021
401 EXPOSURE DURING PREGNANCY 131 0.0021
402 PRE-ECLAMPSIA 10 0.0021
403 HYPERGLYCAEMIA 76 0.0021
404 SERUM FERRITIN INCREASED 11 0.0021
405 ADRENAL DISORDER 4 0.0021
406 CYTOMEGALOVIRUS INFECTION REACTIVATION 9 0.0020
407 HYPERBILIRUBINAEMIA 21 0.0020
408 CATHETER SITE HAEMORRHAGE 5 0.0020
409 EMBOLISM VENOUS 6 0.0020
410 BRAIN ABSCESS 5 0.0020
411 CORONAVIRUS INFECTION 13 0.0020
412 PERIPHERAL ISCHAEMIA 8 0.0020
413 CHEST X-RAY ABNORMAL 6 0.0020
414 ACUTE MYOCARDIAL INFARCTION 56 0.0019
415 BLOOD LACTIC ACID INCREASED 10 0.0019
416 AMYLASE INCREASED 7 0.0019
417 HEPATIC FAILURE 57 0.0019
418 CARDIAC DYSFUNCTION 7 0.0019
419 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
420 CHOLESTASIS 36 0.0019
421 INTESTINAL PERFORATION 21 0.0019
422 INFUSION RELATED REACTION 124 0.0019
423 ACUTE MYELOID LEUKAEMIA RECURRENT 4 0.0019
424 HYPERKALAEMIA 65 0.0019
425 CARDIOVASCULAR INSUFFICIENCY 3 0.0018
426 LYMPHOPENIA 26 0.0018
427 ENCEPHALOPATHY 45 0.0018
428 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 7 0.0018
429 BRADYARRHYTHMIA 3 0.0018
430 GRAFT VERSUS HOST DISEASE IN SKIN 4 0.0018
431 DRUG LEVEL INCREASED 30 0.0018
432 LYMPHOCYTE COUNT DECREASED 32 0.0018
433 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 9 0.0018
434 TEMPERATURE REGULATION DISORDER 4 0.0018
435 CARDIOPULMONARY FAILURE 7 0.0018
436 LUNG CONSOLIDATION 5 0.0018
437 PANCREATITIS ACUTE 40 0.0018
438 FOETAL EXPOSURE DURING PREGNANCY 144 0.0018
439 CHOLECYSTITIS ACUTE 10 0.0018
440 AMMONIA INCREASED 9 0.0018
441 ECCHYMOSIS 12 0.0017
442 CYTOKINE RELEASE SYNDROME 35 0.0017
443 CYTOMEGALOVIRUS COLITIS 4 0.0017
444 BLOOD CHLORIDE INCREASED 3 0.0017
445 CAROTID ARTERY STENOSIS 6 0.0017
446 THERAPY NON-RESPONDER 77 0.0017
447 HYPERTRIGLYCERIDAEMIA 10 0.0017
448 HYPERTENSIVE CRISIS 19 0.0017
449 INJECTION SITE EXTRAVASATION 21 0.0017
450 BRAIN HERNIATION 5 0.0017
451 LIVE BIRTH 14 0.0017
452 KIDNEY TRANSPLANT REJECTION 8 0.0017
453 HALLUCINATIONS, MIXED 7 0.0017
454 DIABETES INSIPIDUS 4 0.0017
455 NORMAL NEWBORN 9 0.0017
456 ADRENAL INSUFFICIENCY 20 0.0016
457 THROMBOTIC MICROANGIOPATHY 16 0.0016
458 SEPSIS 181 0.0016
459 BLOOD IMMUNOGLOBULIN G DECREASED 4 0.0016
460 URINE OUTPUT DECREASED 14 0.0016
461 EPSTEIN-BARR VIRUS INFECTION 10 0.0016
462 STATUS EPILEPTICUS 18 0.0016
463 BLOOD BICARBONATE DECREASED 3 0.0016
464 HYPOTHERMIA 16 0.0016
465 DERMATOMYOSITIS 4 0.0016
466 PRODUCT CONTAMINATION PHYSICAL 4 0.0016
467 NOCARDIOSIS 4 0.0016
468 ARTERIAL THROMBOSIS 3 0.0016
469 UNRESPONSIVE TO STIMULI 40 0.0015
470 SUSPECTED OFF LABEL USE 7 0.0015
471 VASCULAR DEVICE INFECTION 7 0.0015
472 RHINOVIRUS INFECTION 6 0.0015
473 HEPATITIS TOXIC 4 0.0015
474 CARDIOGENIC SHOCK 22 0.0015
475 THROMBOSIS IN DEVICE 5 0.0015
476 ALTERED STATE OF CONSCIOUSNESS 33 0.0015
477 HOSPICE CARE 15 0.0015
478 BLOOD ALBUMIN DECREASED 12 0.0015
479 ANURIA 13 0.0015
480 AZOTAEMIA 6 0.0015
481 AREFLEXIA 4 0.0015
482 SUPRAVENTRICULAR EXTRASYSTOLES 5 0.0015
483 FOETAL GROWTH RESTRICTION 9 0.0015
484 CARDIAC TAMPONADE 7 0.0015
485 BLOOD PHOSPHORUS INCREASED 4 0.0015
486 ARTHRITIS BACTERIAL 6 0.0015
487 ORAL FUNGAL INFECTION 4 0.0015
488 CAESAREAN SECTION 17 0.0015
489 LEUKOPENIA 73 0.0015
490 CAPILLARY LEAK SYNDROME 3 0.0014
491 PRIAPISM 5 0.0014
492 ATELECTASIS 14 0.0014
493 BACTERIAL INFECTION 27 0.0014
494 GAMMA-GLUTAMYLTRANSFERASE INCREASED 32 0.0014
495 DRUG RESISTANCE 37 0.0014
496 STREPTOCOCCAL INFECTION 8 0.0014
497 THERAPY INTERRUPTED 102 0.0014
498 ACUTE PULMONARY OEDEMA 8 0.0014
499 ATRIOVENTRICULAR BLOCK 11 0.0014
500 DRUG INTERACTION 225 0.0014
501 FACIAL PARESIS 5 0.0014
502 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
503 HYPOTENSION 283 0.0014
504 HEART VALVE INCOMPETENCE 4 0.0014
505 PRODUCT ADMINISTRATION ERROR 28 0.0014
506 HAEMOTHORAX 4 0.0014
507 RESPIRATORY ARREST 38 0.0014
508 SUBARACHNOID HAEMORRHAGE 14 0.0014
509 GASTROINTESTINAL NECROSIS 4 0.0014
510 PULMONARY PAIN 4 0.0014
511 HYPOVOLAEMIA 8 0.0014
512 STRIDOR 4 0.0014
513 HYPOPHOSPHATAEMIA 10 0.0014
514 RESPIRATORY RATE INCREASED 12 0.0014
515 PULMONARY EMBOLISM 128 0.0013
516 BACTERIAL TEST POSITIVE 3 0.0013
517 TRANSFUSION 14 0.0013
518 BLOOD CALCIUM DECREASED 15 0.0013
519 MENTAL STATUS CHANGES 37 0.0013
520 LIVER DISORDER 59 0.0013
521 DELIRIUM 46 0.0013
522 BLOOD PRESSURE SYSTOLIC DECREASED 6 0.0013
523 CONDITION AGGRAVATED 396 0.0013
524 RENAL FUNCTION TEST ABNORMAL 6 0.0013
525 CONTRAINDICATED PRODUCT ADMINISTERED 39 0.0013
526 NEUROLEPTIC MALIGNANT SYNDROME 15 0.0013
527 RENAL FAILURE 167 0.0013
528 NEPHROPATHY TOXIC 14 0.0012
529 REBOUND EFFECT 14 0.0012
530 PREMATURE LABOUR 7 0.0012
531 ATRIAL FIBRILLATION 119 0.0012
532 RASH MACULO-PAPULAR 27 0.0012
533 SUSPECTED COVID-19 4 0.0012
534 STRESS CARDIOMYOPATHY 7 0.0012
535 PULMONARY FIBROSIS 23 0.0012
536 INTENTIONAL PRODUCT USE ISSUE 105 0.0012
537 SINUS TACHYCARDIA 17 0.0012
538 CEREBRAL INFARCTION 29 0.0012
539 DRUG ERUPTION 21 0.0012
540 WRONG PRODUCT ADMINISTERED 8 0.0012
541 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 6 0.0012
542 FAILURE TO THRIVE 6 0.0012
543 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
544 PARTIAL SEIZURES 6 0.0011
545 ERYTHEMA NODOSUM 4 0.0011
546 ORAL CANDIDIASIS 15 0.0011
547 MELAENA 25 0.0011
548 MYOCARDITIS 13 0.0011
549 PULMONARY TOXICITY 8 0.0011
550 LIVER FUNCTION TEST ABNORMAL 32 0.0011
551 ASPIRATION 12 0.0011
552 HEPATITIS 28 0.0011
553 IMMUNE THROMBOCYTOPENIA 5 0.0011
554 THERAPY PARTIAL RESPONDER 17 0.0011
555 BUNDLE BRANCH BLOCK RIGHT 5 0.0011
556 EOSINOPHIL COUNT INCREASED 9 0.0011
557 IMMUNODEFICIENCY 16 0.0011
558 PULMONARY ALVEOLAR HAEMORRHAGE 6 0.0011
559 HYDRONEPHROSIS 8 0.0011
560 PROTEIN TOTAL DECREASED 4 0.0011
561 VENTRICULAR EXTRASYSTOLES 11 0.0011
562 GENERAL PHYSICAL HEALTH DETERIORATION 121 0.0010
563 LIPASE INCREASED 8 0.0010
564 CLOSTRIDIUM DIFFICILE COLITIS 11 0.0010
565 STILLBIRTH 5 0.0010
566 PNEUMONIA 334 0.0010
567 HYPOALBUMINAEMIA 8 0.0010
568 ABORTION 3 0.0010
569 CYANOSIS 16 0.0010
570 PERITONITIS 21 0.0010
571 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 6 0.0010
572 BIPOLAR DISORDER 11 0.0010
573 CEREBRAL ATROPHY 4 0.0010
574 PLATELET COUNT INCREASED 13 0.0010
575 LACTIC ACIDOSIS 32 0.0010
576 TOXIC EPIDERMAL NECROLYSIS 15 0.0010
577 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
578 DECUBITUS ULCER 8 0.0010
579 DEMYELINATION 4 0.0010
580 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 5 0.0010
581 THROMBOCYTOPENIA 109 0.0010
582 TACHYCARDIA 86 0.0010
583 HAEMATOMA 25 0.0010
584 GASTROINTESTINAL PERFORATION 4 0.0010
585 BLOOD CREATININE DECREASED 3 0.0010
586 BRAIN OEDEMA 12 0.0009
587 BLOOD PRESSURE DECREASED 63 0.0009
588 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
589 ABSCESS LIMB 4 0.0009
590 CARDIAC FAILURE CHRONIC 4 0.0009
591 WHITE BLOOD CELL COUNT INCREASED 36 0.0009
592 BLOOD CREATINE PHOSPHOKINASE INCREASED 27 0.0009
593 HYPOMAGNESAEMIA 13 0.0009
594 INTERSTITIAL LUNG DISEASE 45 0.0009
595 PYELONEPHRITIS 8 0.0009
596 PULMONARY CONGESTION 12 0.0009
597 ABDOMINAL ABSCESS 4 0.0009
598 CARDIAC FAILURE ACUTE 6 0.0009
599 APNOEA 7 0.0009
600 ISCHAEMIC STROKE 16 0.0009
601 HAEMOLYTIC ANAEMIA 8 0.0009
602 PAPILLOEDEMA 4 0.0009
603 DEATH 762 0.0009
604 NO ADVERSE EVENT 160 0.0009
605 ATRIAL FLUTTER 7 0.0009
606 DRUG LEVEL ABOVE THERAPEUTIC 4 0.0009
607 PRODUCT DISPENSING ERROR 19 0.0009
608 ISCHAEMIA 4 0.0009
609 PRODUCT USE IN UNAPPROVED INDICATION 215 0.0009
610 UROSEPSIS 8 0.0009
611 HAEMATOCRIT DECREASED 17 0.0009
612 EJECTION FRACTION DECREASED 13 0.0008
613 TUMOUR MARKER INCREASED 4 0.0008
614 BODY TEMPERATURE INCREASED 17 0.0008
615 PANCREATITIS 44 0.0008
616 HEPATITIS CHOLESTATIC 5 0.0008
617 GASTROINTESTINAL HAEMORRHAGE 69 0.0008
618 CAROTID ARTERY OCCLUSION 3 0.0008
619 DISEASE RECURRENCE 39 0.0008
620 MYOPATHY 7 0.0008
621 HYPERVOLAEMIA 4 0.0008
622 CHOLANGITIS 5 0.0008
623 SMALL FOR DATES BABY 4 0.0008
624 DISEASE PROGRESSION 95 0.0008
625 BLOOD POTASSIUM INCREASED 13 0.0008
626 C-REACTIVE PROTEIN INCREASED 29 0.0008
627 RHABDOMYOLYSIS 33 0.0008
628 INFUSION SITE PAIN 10 0.0008
629 ELECTROLYTE IMBALANCE 9 0.0008
630 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
631 DEEP VEIN THROMBOSIS 50 0.0008
632 HEPATITIS ACUTE 5 0.0008
633 RETINAL DETACHMENT 7 0.0008
634 DEPRESSED LEVEL OF CONSCIOUSNESS 30 0.0008
635 MENINGITIS 5 0.0007
636 INCORRECT PRODUCT ADMINISTRATION DURATION 16 0.0007
637 PULMONARY THROMBOSIS 8 0.0007
638 INFARCTION 5 0.0007
639 PHARYNGEAL SWELLING 7 0.0007
640 MALNUTRITION 8 0.0007
641 PULMONARY OEDEMA 32 0.0007
642 HEPATOMEGALY 7 0.0007
643 BUNDLE BRANCH BLOCK LEFT 3 0.0007
644 MITRAL VALVE INCOMPETENCE 8 0.0007
645 BRONCHOSPASM 10 0.0007
646 PARALYSIS 10 0.0007
647 BRAIN INJURY 7 0.0007
648 TOXIC SKIN ERUPTION 7 0.0007
649 EMPHYSEMA 7 0.0007
650 FLUID OVERLOAD 10 0.0007
651 EOSINOPHILIA 12 0.0007
652 NEUTROPHIL COUNT INCREASED 7 0.0007
653 HAEMOPTYSIS 19 0.0007
654 PRODUCT USE ISSUE 128 0.0007
655 CARDIOTOXICITY 6 0.0007
656 HEPATITIS B 4 0.0007
657 PNEUMONITIS 18 0.0007
658 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0007
659 CIRCULATORY COLLAPSE 11 0.0006
660 PARANOIA 11 0.0006
661 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 16 0.0006
662 HEART RATE IRREGULAR 14 0.0006
663 CARDIOMYOPATHY 9 0.0006
664 BREATH SOUNDS ABNORMAL 3 0.0006
665 MANIA 10 0.0006
666 ABDOMINAL TENDERNESS 3 0.0006
667 HEMIPLEGIA 5 0.0006
668 FUNGAL INFECTION 20 0.0006
669 AGITATION 44 0.0006
670 CLOSTRIDIUM DIFFICILE INFECTION 13 0.0006
671 RED BLOOD CELL COUNT DECREASED 17 0.0006
672 PRODUCT LABEL ISSUE 4 0.0006
673 NEUTROPHIL COUNT DECREASED 24 0.0006
674 CHILLS 69 0.0006
675 HYPERLIPIDAEMIA 7 0.0006
676 POLYNEUROPATHY 7 0.0006
677 HAEMOGLOBIN DECREASED 60 0.0006
678 DRUG INEFFECTIVE 768 0.0006
679 RESPIRATION ABNORMAL 4 0.0006
680 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
681 EXTRASYSTOLES 4 0.0006
682 INTERCEPTED PRODUCT PREPARATION ERROR 7 0.0006
683 HYPERCALCAEMIA 7 0.0006
684 CEREBRAL HAEMORRHAGE 20 0.0006
685 ANAL ABSCESS 3 0.0006
686 MOUTH HAEMORRHAGE 4 0.0005
687 HEPATIC STEATOSIS 10 0.0005
688 PLATELET COUNT DECREASED 57 0.0005
689 PYREXIA 185 0.0005
690 LUNG DISORDER 26 0.0005
691 COMA 25 0.0005
692 CARDIAC FAILURE 42 0.0005
693 DIFFUSE LARGE B-CELL LYMPHOMA 4 0.0005
694 HAEMORRHAGIC STROKE 4 0.0005
695 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
696 ANAPHYLACTIC SHOCK 13 0.0005
697 CHOLECYSTITIS 6 0.0005
698 BLOOD DISORDER 4 0.0005
699 HYPOKALAEMIA 23 0.0005
700 MYASTHENIA GRAVIS 4 0.0005
701 PLEURAL EFFUSION 30 0.0005
702 ASPHYXIA 4 0.0005
703 HICCUPS 4 0.0005
704 GENERALISED OEDEMA 6 0.0005
705 AGRANULOCYTOSIS 9 0.0005
706 ACUTE CORONARY SYNDROME 4 0.0005
707 RASH ERYTHEMATOUS 23 0.0005
708 NEUTROPENIA 65 0.0005
709 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 14 0.0005
710 ANAPHYLACTIC REACTION 26 0.0005
711 HYPOPHAGIA 12 0.0005
712 LETHARGY 27 0.0005
713 CARDIAC FLUTTER 3 0.0005
714 ORAL HERPES 9 0.0005
715 DIABETIC KETOACIDOSIS 11 0.0005
716 DYSPNOEA 259 0.0005
717 NEUROTOXICITY 8 0.0005
718 DEVICE RELATED INFECTION 7 0.0005
719 TUMOUR LYSIS SYNDROME 4 0.0005
720 MEDICATION ERROR 25 0.0004
721 BRONCHIECTASIS 3 0.0004
722 OSTEOMYELITIS 8 0.0004
723 HALLUCINATION, AUDITORY 7 0.0004
724 MYOCARDIAL ISCHAEMIA 5 0.0004
725 THROMBOSIS 35 0.0004
726 DIVERTICULITIS 12 0.0004
727 PULMONARY HYPERTENSION 9 0.0004
728 POST PROCEDURAL HAEMORRHAGE 5 0.0004
729 ANGIOEDEMA 19 0.0004
730 RENAL DISORDER 20 0.0004
731 VASCULITIS 5 0.0004
732 NEPHROPATHY 4 0.0004
733 CHOLELITHIASIS 14 0.0004
734 FLANK PAIN 4 0.0004
735 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
736 PRODUCT STORAGE ERROR 37 0.0004
737 FEBRILE NEUTROPENIA 28 0.0004
738 SUBDURAL HAEMATOMA 6 0.0004
739 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
740 SEIZURE 48 0.0004
741 HAEMATURIA 14 0.0004
742 CYTOPENIA 5 0.0004
743 RESPIRATORY DEPRESSION 5 0.0004
744 MUSCLE SPASTICITY 5 0.0004
745 WHITE BLOOD CELL COUNT DECREASED 44 0.0004
746 WHEEZING 24 0.0004
747 RENAL INJURY 12 0.0004
748 ARRHYTHMIA 19 0.0004
749 OSTEONECROSIS 13 0.0004
750 CARDIOVASCULAR DISORDER 10 0.0004
751 BLINDNESS 16 0.0004
752 ACUTE MYELOID LEUKAEMIA 6 0.0004
753 HYPERTENSION 81 0.0004
754 HYPERHIDROSIS 49 0.0004
755 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
756 SUDDEN DEATH 4 0.0004
757 PRODUCT PRESCRIBING ERROR 9 0.0004
758 ASCITES 11 0.0004
759 HEPATIC CIRRHOSIS 7 0.0004
760 NEURALGIA 9 0.0004
761 INFECTION 53 0.0004
762 APHASIA 11 0.0004
763 STEVENS-JOHNSON SYNDROME 8 0.0004
764 SKIN INFECTION 4 0.0004
765 ANAEMIA 68 0.0004
766 HAEMATEMESIS 9 0.0004
767 HEMIPARESIS 6 0.0004
768 HYPOGLYCAEMIA 17 0.0004
769 INTERNAL HAEMORRHAGE 4 0.0003
770 BONE MARROW FAILURE 7 0.0003
771 FLUSHING 35 0.0003
772 LABORATORY TEST ABNORMAL 10 0.0003
773 PSYCHOTIC DISORDER 10 0.0003
774 PULMONARY MASS 5 0.0003
775 BLOOD PRESSURE FLUCTUATION 8 0.0003
776 TREATMENT FAILURE 27 0.0003
777 CHEST PAIN 60 0.0003
778 LYMPHOMA 5 0.0003
779 DERMATITIS ALLERGIC 4 0.0003
780 ABSCESS 5 0.0003
781 SEROTONIN SYNDROME 6 0.0003
782 RASH PAPULAR 7 0.0003
783 AFFECT LABILITY 3 0.0003
784 SENSORY DISTURBANCE 5 0.0003
785 TREMOR 51 0.0003
786 URINARY TRACT INFECTION 52 0.0003
787 PANCYTOPENIA 17 0.0003
788 BLISTER 17 0.0003
789 BLOOD PRESSURE ABNORMAL 6 0.0003
790 DIABETES MELLITUS 23 0.0003
791 CEREBROVASCULAR ACCIDENT 51 0.0003
792 BLOOD POTASSIUM DECREASED 9 0.0003
793 EXTRA DOSE ADMINISTERED 12 0.0003
794 RASH PRURITIC 16 0.0003
795 PALLOR 8 0.0003
796 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
797 SWELLING 27 0.0003
798 MOUTH ULCERATION 6 0.0003
799 DYSPHAGIA 27 0.0003
800 BLINDNESS UNILATERAL 4 0.0003
801 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
802 COUGH 79 0.0003
803 THERAPEUTIC RESPONSE DECREASED 17 0.0003
804 OEDEMA 15 0.0003
805 END STAGE RENAL DISEASE 5 0.0003
806 HEART RATE INCREASED 27 0.0003
807 SEDATION 7 0.0003
808 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
809 HYPONATRAEMIA 15 0.0003
810 HYPOAESTHESIA ORAL 4 0.0003
811 PROTEINURIA 5 0.0003
812 HYPERSENSITIVITY 48 0.0003
813 DELUSION 4 0.0003
814 RASH MACULAR 9 0.0003
815 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
816 HAEMORRHAGE 26 0.0002
817 FULL BLOOD COUNT DECREASED 5 0.0002
818 PRESYNCOPE 6 0.0002
819 CHEST DISCOMFORT 25 0.0002
820 CARDIOMEGALY 3 0.0002
821 BURNING SENSATION 17 0.0002
822 EXPIRED PRODUCT ADMINISTERED 8 0.0002
823 DYSARTHRIA 9 0.0002
824 ERYTHEMA 49 0.0002
825 HAEMATOCHEZIA 13 0.0002
826 RESPIRATORY TRACT INFECTION 6 0.0002
827 SYNCOPE 23 0.0002
828 FEELING HOT 14 0.0002
829 COLD SWEAT 4 0.0002
830 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
831 LYMPHADENOPATHY 8 0.0002
832 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
833 JAUNDICE 6 0.0002
834 THROAT TIGHTNESS 6 0.0002
835 CHROMATURIA 5 0.0002
836 TOXICITY TO VARIOUS AGENTS 37 0.0002
837 DEHYDRATION 29 0.0002
838 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
839 PERICARDIAL EFFUSION 5 0.0002
840 RASH 94 0.0002
841 DISCOMFORT 13 0.0002
842 BLOOD SODIUM DECREASED 4 0.0002
843 COLITIS 8 0.0002
844 CONFUSIONAL STATE 34 0.0002
845 LIP SWELLING 7 0.0002
846 URINARY RETENTION 7 0.0002
847 PRODUCTIVE COUGH 10 0.0002
848 ANOSMIA 3 0.0002
849 TREATMENT NONCOMPLIANCE 11 0.0002
850 ABORTION SPONTANEOUS 8 0.0002
851 FEEDING DISORDER 4 0.0002
852 MYELOSUPPRESSION 7 0.0002
853 INCORRECT DOSE ADMINISTERED 44 0.0002
854 DYSURIA 7 0.0002
855 FAECES DISCOLOURED 4 0.0002
856 SWELLING FACE 12 0.0002
857 SOMNOLENCE 37 0.0002
858 PRODUCT PRESCRIBING ISSUE 4 0.0002
859 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
860 BLOOD GLUCOSE INCREASED 34 0.0002
861 TYPE 2 DIABETES MELLITUS 6 0.0002
862 ASTHENIA 67 0.0002
863 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 32 0.0002
864 ILLNESS 18 0.0002
865 URTICARIA 29 0.0002
866 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
867 LACRIMATION INCREASED 5 0.0002
868 BONE DISORDER 3 0.0002
869 RESTLESSNESS 6 0.0002
870 EPILEPSY 5 0.0002
871 EYE SWELLING 6 0.0002
872 MENTAL DISORDER 7 0.0002
873 EPISTAXIS 12 0.0002
874 NERVOUS SYSTEM DISORDER 5 0.0002
875 UNEVALUABLE EVENT 12 0.0002
876 HEAD INJURY 5 0.0002
877 CHRONIC KIDNEY DISEASE 12 0.0002
878 NEUROPATHY PERIPHERAL 15 0.0002
879 CYSTITIS 5 0.0002
880 THROAT IRRITATION 7 0.0002
881 INFLAMMATION 8 0.0002
882 ANXIETY 44 0.0002
883 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
884 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
885 ABDOMINAL DISTENSION 16 0.0002
886 VOMITING 72 0.0002
887 SKIN DISCOLOURATION 7 0.0002
888 IMPAIRED HEALING 5 0.0002
889 BLOOD PRESSURE INCREASED 23 0.0002
890 PERIPHERAL SWELLING 23 0.0001
891 PAIN OF SKIN 4 0.0001
892 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
893 DECREASED APPETITE 34 0.0001
894 POLLAKIURIA 6 0.0001
895 NEOPLASM PROGRESSION 5 0.0001
896 WOUND 4 0.0001
897 INTENTIONAL DOSE OMISSION 4 0.0001
898 RECTAL HAEMORRHAGE 6 0.0001
899 CARDIAC DISORDER 13 0.0001
900 CELLULITIS 7 0.0001
901 PRODUCT DOSE OMISSION 9 0.0001
902 ABDOMINAL PAIN 32 0.0001
903 OVERDOSE 29 0.0001
904 DYSPNOEA EXERTIONAL 5 0.0001
905 NAUSEA 105 0.0001
906 NEPHROLITHIASIS 6 0.0001
907 TINNITUS 6 0.0001
908 DIARRHOEA 84 0.0001
909 DISTURBANCE IN ATTENTION 7 0.0001
910 SWOLLEN TONGUE 4 0.0001
911 ARTHRITIS 10 0.0001
912 DISORIENTATION 5 0.0001
913 LUNG NEOPLASM MALIGNANT 5 0.0001
914 EYE IRRITATION 7 0.0001
915 MALAISE 53 0.0001
916 AGEUSIA 3 0.0001
917 PRURITUS 46 0.0001
918 HALLUCINATION 9 0.0001
919 OROPHARYNGEAL PAIN 11 0.0001
920 MYOCARDIAL INFARCTION 20 0.0001
921 INTENTIONAL PRODUCT MISUSE 10 0.0001
922 DRUG INTOLERANCE 11 0.0001
923 PALPITATIONS 13 0.0001
924 ACCIDENTAL OVERDOSE 4 0.0001
925 LOSS OF CONSCIOUSNESS 14 0.0001
926 ABNORMAL DREAMS 3 0.0001
927 COGNITIVE DISORDER 5 0.0001
928 BLOOD GLUCOSE DECREASED 5 0.0001
929 ILL-DEFINED DISORDER 6 0.0001
930 DYSKINESIA 4 0.0001
931 DIZZINESS 49 0.0001
932 PAIN 60 0.0001
933 CONSTIPATION 21 0.0001
934 FALL 32 0.0001
935 FEELING ABNORMAL 23 0.0001
936 BACK PAIN 22 0.0001
937 BRONCHITIS 7 0.0001
938 ABDOMINAL PAIN UPPER 19 0.0001
939 HEADACHE 56 0.0001
940 EYE PAIN 5 0.0001
941 MYALGIA 15 0.0001
942 MUSCULAR WEAKNESS 10 0.0001
943 CARDIAC FAILURE CONGESTIVE 7 0.0001
944 HERPES ZOSTER 5 0.0001
945 MULTIPLE SCLEROSIS 4 0.0001
946 STOMATITIS 5 0.0001
947 OEDEMA PERIPHERAL 10 0.0001
948 FATIGUE 61 0.0001
949 SINUSITIS 8 0.0001
950 AMNESIA 5 0.0001
951 SUICIDAL IDEATION 7 0.0001
952 ALOPECIA 15 0.0001
953 PARAESTHESIA 12 0.0001
954 PRODUCT DOSE OMISSION ISSUE 22 0.0001
955 CONTUSION 7 0.0001
956 DEVICE MALFUNCTION 5 0.0001
957 SLEEP DISORDER 5 0.0001
958 BALANCE DISORDER 6 0.0001
959 UNDERDOSE 5 0.0001
960 NASAL CONGESTION 4 0.0001
961 DYSGEUSIA 5 0.0001
962 ADVERSE DRUG REACTION 6 0.0001
963 VERTIGO 4 0.0001
964 VISION BLURRED 9 0.0001
965 ADVERSE EVENT 6 0.0001
966 HOSPITALISATION 10 0.0001
967 INSOMNIA 16 0.0001
968 MUSCLE SPASMS 11 0.0001
969 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
970 INJURY 4 0.0001
971 ARTHRALGIA 23 0.0001
972 PAIN IN EXTREMITY 16 0.0001
973 WEIGHT DECREASED 15 0.0001
974 HYPOAESTHESIA 8 0.0001
975 GAIT DISTURBANCE 10 0.0001
976 INFLUENZA LIKE ILLNESS 4 0.0000
977 DEPRESSION 11 0.0000
978 INFLUENZA 5 0.0000
979 GASTROINTESTINAL DISORDER 4 0.0000
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
981 MEMORY IMPAIRMENT 6 0.0000
982 NASOPHARYNGITIS 8 0.0000
983 MIGRAINE 4 0.0000
984 EMOTIONAL DISTRESS 5 0.0000
985 ASTHMA 4 0.0000
986 INJECTION SITE ERYTHEMA 4 0.0000
987 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
988 ABDOMINAL DISCOMFORT 4 0.0000
989 INJECTION SITE PAIN 4 0.0000